Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome

NCT03090620 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Anticholinergics Toxicity

Interventions

DRUG: Physostigmine
DRUG: Lorazepam

Sponsor

University of Colorado, Denver

Collaborators

[object Object]